Tamiya, Motohiro http://orcid.org/0000-0001-6529-3092
Kunimasa, Kei
Nishino, Kazumi
Matsumoto, Shingo
Kawachi, Hayato
Kuno, Kika
Inoue, Takako
Kuhara, Hanako
Imamura, Fumio
Goto, Koichi
Kumagai, Toru
Article History
Received: 29 May 2020
Accepted: 16 June 2020
First Online: 18 June 2020
Compliance with ethical standards
:
: Motohiro Tamiya has lecture fee from AstraZeneca and Boehringer Ingelheim and other authors have no conflicts of interest to declare under consideration for publication.
: Institutional review board (IRB) approval for this study was obtained from the Medical Research Ethics Committee of Osaka International Cancer Institute.
: Waived by the IRB because of the retrospective nature of this case report. However, we got the informed consent of analyzing the cfDNA byGuardant360.